|
[an error occurred while processing this directive]
|
Item #15
Lipid
Soluble Thiamine May Benefit Diabetes Patients
Lipid
soluble Thiamine helps to prevent diabetic retinopathy damage.
New
research results point to a possible role for lipid soluble thiamine
in preventing some of the most common side effects of diabetes.
Researchers reported that diabetic retinopathy damage may be avoided
through the use of high doses of lipid soluble thiamine.
High
levels of glucose are responsible for microvascular damage and the
resulting blindness, nerve damage, kidney failure and atherosclerosis
often associated with diabetes.
Researchers
at Albert Einstein College of Medicine in New York and their
colleagues in Germany recently reported that this damage may be
avoided through the use of high doses of lipid soluble thiamine.
The
scientists looked at the development of diabetic retinopathy in a rat
model of diabetes. Treating the animals with high doses of lipid
soluble thiamine for 36 weeks completely blocked the development of
retinal damage. They were also able to show that the lipid soluble
thiamine worked by activating the enzyme transketolase, a key
thiamine-dependent enzyme involved in carbohydrate metabolism.
The
data indicates that treatment of diabetic patients with benfotiamine
or other lipid-soluble thiamine derivatives might prevent or delay the
development of diabetic complications." The key function that
they believe is important is the increase in the transketolase
activity. As the researchers reported, standard water soluble
thiamine does not stay around in the body long enough to provide
the increase in activity needed to make a difference. The lipid
soluble forms of thiamine are much more bioavailable, thus
significantly increasing the transketolase activity.
Although
these results have not yet been confirmed in humans, they point to
exciting new therapeutic opportunities for diabetes patients, 20,000
of whom now go blind every year as a direct result of diabetic
retinopathy. There are
lipid soluble forms of thiamine available without a prescription.
Hammes
HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus
A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee
M.
Benfotiamine
blocks three major pathways of hyperglycemic damage and prevents
experimental diabetic retinopathy. Nat
Med. 2003 Mar;9(3):294-9.
[an error occurred while processing this directive]
|
[an error occurred while processing this directive]
|